El interés en corto de Edreams Odigeo da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Edreams Odigeo. Los datos de interés en corto se actualizan cada dos semanas.

Edreams Odigeo (OTC:EDDRF) Bolsa, Informe de interés en corto

Edreams Odigeo SA is an online travel company that uses technology and builds on relationships with suppliers, product know-how, and marketing expertise to attract and enable customers to search, plan, and book a broad range of travel products and services. Its travel solutions content includes flights, hotels, dynamic packages (flight plus hotel), trains, car rentals, and ancillaries (such as seats, bags, and insurance), which are sourced from a wide range of suppliers which include airlines, hotels, GDS aggregators, white label partners, car rental suppliers, train operators, and insurance providers. The company's segments include France; Southern Europe (Spain + Italy); and Northern Europe (Germany + Nordics + UK).

EDREAMS ODIGEO SA ORD by EDreams Odigeo SA

Edreams Odigeo SA

Barrington Research analyst Gary Prestopino maintains LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) with a Outperform and maintains $60 price target.

News

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on LKQ, Maintains $60 Price Target

Barrington Research analyst Michael Petusky maintains Option Care Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) with a Outperform and maintains $38 price target.

OPCH

Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target

HemoSphere Alta&#x2122; Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical Situations
FRANKLIN LAKES, N.J., April 21, 2025 /PRNewswire/ --&nbsp;BD (Becton, Dickinson and Company) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>), a leading global medical technology company, has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (AI) based algorithms that can help clinicians proactively address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
HemoSphere Alta&#x2122; platform is the company's most advanced hemodynamic monitoring technology available and is the first major product launch from the Advanced Patient Monitoring business since its acquisition by BD. The new product advances BD's leadership in smart, connected care technologies that use clinical data and AI to help clinicians improve patient outcomes and optimize clinical workflows.
 &nbsp;

BD Unveils HemoSphere Alta Advanced Monitoring Platform With Predictive, AI Based Algorithms

On April&nbsp;17, 2025, the U.S. Department of the Army announced through the publication of its Justification to Fair Opportunity ("JEFO") on SAM.gov that it will extend the current period of performance for the various task orders under the&nbsp;Logistics Civil Augmentation Program V indefinite delivery and indefinite quantity contract to support U.S. military operations worldwide ("LOGCAP V") with V2X,&nbsp;Inc. The Company is one of four award recipients of LOGCAP V and has several task orders, including the Kuwait Task Order,&nbsp;Iraq Task Order and INDOPACOM Task Order, among others, each of which is scheduled to extend through June&nbsp;2030.

Government

Regulations

V2X Inc. Secures Extended Military Support Contracts Under US Army's LOGCAP V Program

<a href="https://www.reuters.com/world/china/huawei-readies-new-ai-chip-mass-shipment-china-seeks-nvidia-alternatives-sources-2025-04-21/" title="https://www.reuters.com/world/china/huawei-readies-new-ai-chip-mass-shipment-china-seeks-nvidia-alternatives-sources-2025-04-21/">https://www.reuters.com/world/china/huawei-readies-new-ai-chip-mass-shipment-china-seeks-nvidia-alternatives-sources-2025-04-21/</a>

Tech

NVDA

Reuters Reported Earlier Huawei Preparing New AI Chip For Mass Shipment As Nvidia Alternative

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1.png" alt="" class="wp-image-11026" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The listing was the first in the U.S. by a Chinese premium tea drink maker, which prides itself on the simplicity of its products and focus on the country's ancient tea culture
Premium tea drink maker&nbsp;Chagee Holdings Ltd.&nbsp;(CHA.US)&nbsp;<a href="https://www.globenewswire.com/news-release/2025/04/17/3063193/0/en/Chagee-Holdings-Limited-Announces-Pricing-of-Initial-Public-Offering.html">raised</a>&nbsp;$411 million (3 billion yuan) this week in the biggest IPO this year by a Chinese company, setting itself apart from a crowded group not only by being first to list in the U.S., but also with its traditional approach to one of China's most famous drinks.
The company raised the sum by selling 14.7 million American depositary shares (ADS) to investors for $28 each and could raise an additional $61.6 million if its underwriters exercise an overallotment option. That makes it the biggest U.S. IPO by a Chinese company since robotaxi operator Pony AI raised about $400 million in a Nasdaq IPO last November. Chagee's stock rose 15.9% on Thursday, its first trading day, valuing the company at $5.95 billion.
Founded in 2017 in Southwest China's Yunnan province, famous for its pu'er-style teas, Chagee has set itself apart from its peers with its simpler, more purist approach to China's tea culture that dates back thousands of years. The company likes to say that such culture is "in its bones," with most of its drinks consisting of milk and tea in various combinations.
That differs markedly from its rivals, many of those listed in Hong Kong, that add a wide range of ingredients to their products, from tapioca pearls, to cheese foam and fruit. The company also emphasizes traditional themes in its packaging and store decorations, including a logo inspired from Consort Yu, a famous figure in Peking Opera.
Chagee is also famous for its homier, more comfortable stores, with some likening that to the approach used by global coffee giant Starbucks. Unlike most of its rivals, whose shops often consist of little more than a window where customers can grab their order and go, Chagee's shops contain seating areas where people can consume their drinks, reminiscent of Starbucks' "third place" concept.
Also like Starbucks, the company prides itself on its treatment of employees, and invited some of those everyday workers, along with some of its franchisees, to ring the opening bell when its shares started trading on the Nasdaq.
Chagee is very much like its peers in reporting explosive growth over the last few years, riding a wave of popularity for their high-end tea drinks among China's growing urban class. Its store count jumped about sixfold from 1,087 shops in the fourth quarter of 2022 to 6,440 at the end of 2024, with franchisees accounting for 97% of those. The company's revenue has grown at a similar rate, rising to 12.4 billion yuan ($1.7 billion) last year from 492 million yuan in 2022.
The company recorded its first profit of 803 million yuan in 2023, and the figure more than tripled last year to 2.51 billion yuan.
In addition to its core China operation, Chagee also sees global expansion as a major new frontier going forward. The company disclosed in its prospectus that it is aiming to operate 1,000 to 1,500 global stores by the end of this year, and has also separately confirmed it plans to open its first U.S. store in Los Angeles later this year.

Asia

Equities

IPOs

Nasdaq IPO Positions Chagee For Global Expansion

Wells Fargo initiates coverage on Staar Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) with a Equal-Weight rating and announces Price Target of $17.

Initiation

STAA

Wells Fargo Initiates Coverage On Staar Surgical with Equal-Weight Rating, Announces Price Target of $17

Piper Sandler analyst Matt Farrell maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Overweight and raises the price target from $1100 to $1150.

NFLX

Piper Sandler Maintains Overweight on Netflix, Raises Price Target to $1150

Money‑management guru Dave&nbsp;Ramsey is urging Americans to treat Social Security as a bonus, not a backbone, warning that the program's cash crunch could slice benefits within a decade.
What Happened: "Don't count on it. Or don't count on all of it," a Ramsey Solutions blog <a href="https://www.ramseysolutions.com/retirement/how-does-social-security-work#cookie-banner">post</a> says, bluntly rebranding the program as "Social Insecurity.
The alarm reflects the latest Social Security Trustees <a href="https://www.ssa.gov/oact/trsum/">report</a>, which projects the combined retirement and disability trust funds will run dry in 2035; ongoing payroll taxes would then cover only about 83 percent of promised checks. Demographic math compounds the squeeze: 2.7 workers now support each beneficiary, a ratio expected to fall to 2.4 by 2035 as baby boomers swell the over‑65 population from 61 million to 77 million.
Fear of a haircut is widespread. An AARP <a href="https://www.aarp.org/social-security/benefits-current-status-future-stability/">survey</a> found 75 percent of Americans 50 and older doubt the system will be there when they need it.
See also: <a href="https://www.benzinga.com/25/04/44829975/joe-biden-calls-social-security-a-sacred-promise-slams-trump-administrations-efforts-to-damage-the-program-theyre-shooting-first-and-aiming-later">Joe Biden Calls Social Security A &#8216;Sacred Promise,&#8217; Slams Trump Administration&#8217;s Efforts To Damage The Program: &#8216;They&#8217;re Shooting First And Aiming Later&#8217;</a>
Lawmakers have floated fixes ranging from higher payroll caps to later retirement ages, but Congress has failed to pass a solvency package since 1983. Ramsey's advice: assume reform stalls and build a private nest egg. "If by some miracle Social Security is around when you retire, you'll have some extra money to work with," he writes. "But understand, it's your job to take care of you and your family, not Uncle Sam's."
With trust‑fund depletion inching closer each spring, the personal‑finance host's blunt mantra lands as a rallying cry: plan for less, save for more, and treat any future check as gravy.
What To Know: Ramsey has previously warned that Social Security was never meant to fund a full retirement. The average 2025 benefit of&nbsp;$1,976 a month leaves most retirees short, so he <a href="https://www.benzinga.com/personal-finance/25/01/43064384/dave-ramseys-top-warnings-about-social-securitys-flaws-and-how-to-protect-your-financial-future">urges people</a> to become debt‑free, stock an emergency fund, and invest 15% of their income for the future.
He also flags the program's <a href="https://www.benzinga.com/24/12/42273289/suze-orman-slams-social-security-fearmongering-you-really-think-washington-is-going-to-do-nothing-and-cut-benefits-by-25-cmon">shaky outlook</a>: its trust funds could run dry by&nbsp;2035, cutting payments by roughly a quarter as the worker‑to‑beneficiary ratio shrinks. Ramsey tells clients to view Social Security as a bonus, <a href="https://www.benzinga.com/personal-finance/24/08/40374894/financial-guru-dave-ramsey-advises-take-social-security-at-62-but-this-essential-step-is-non-neg">claim at&nbsp;62</a> only if they invest the checks, and build wealth through disciplined saving rather than rely on Washington.
Read next: <a href="https://www.benzinga.com/personal-finance/25/04/44890948/she-collected-her-moms-social-security-for-25-years-now-shes-facing-justice">She Collected Her Mom&#8217;s Social Security For 25 Years — Now She&#8217;s Facing Justice</a>

Education

General

Dave Ramsey Tells Retirees 'Don't Count On it, Or Don't Count On All Of It' — Why He Doubts Social Security's Future

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Marwan Noel Sabbagh, MD, Professor of Neurology at Barrow Neurological Institute and Chairman of Anavex's Scientific Advisory Board gave an oral presentation titled, "Oral Blarcamesine Novel Mechanism for Alzheimer Disease: Autophagy Restoration through Upstream SIGMAR1 Activation Clinical Efficacy Phase IIb/III Trial" at the 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East.
The ‘9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East' was held April 18-20, 2025 in Abu Dhabi, United Arab Emirates (UAE). The meeting convened clinicians including neurologists, psychiatrists, and geriatricians, nurses, public health workers, researchers, social workers, students, caregivers, and community advocates from the Middle East and North Africa (termed the MENA region), USA, Europe and other countries with an interest in epidemiology, clinical/research, medicine, basic science, and healthcare advocacy related to Alzheimer's disease and related disorders (ADRD) in the region. Specifically, an emphasis on region specific healthcare delivery were addressed.

AVXL

Anavex Says Marwan Noel Sabbagh Presents Blarcamesine Phase IIb/III Findings At 9th International Conference On Alzheimer's Disease and Related Disorders in Middle East

Chinese battery manufacturer CATL (Contemporary Amperex Technology Co. Limited) has launched the second-generation ‘Shenxing' fast-charging battery.
What Happened: The company announced the second-generation battery at an event in Shanghai, reported Reuters on Monday. Shenxing batteries would power over 67 new EVs this year, CATL's Chief Technology Officer, Gao Huan, said.
The new battery would enable a range of 520 km or approximately 323 miles on a 5-minute charge. The battery can also be charged from 0% to 80% in 15 minutes in cold weather.
The report also shares that, besides the new battery, CATL also unveiled a new brand called Naxtra for the company's Sodium-ion batteries. Sodium-ion batteries could help reduce the risk of a fire in EVs, some experts suggest.
Why It Matters: Last year, CATL, whose customers also include the likes of Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VLKAF#OTC">VLKAF</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), was seeking over <a href="https://www.benzinga.com/news/24/07/39745306/tesla-supplier-catl-seeks-1-5b-funding-to-expand-global-ev-battery-supply-chain">$1.5 billion in funding</a> to bolster its EV battery supply chain.&nbsp;
Elsewhere, fast-charging tech throughout the globe is experiencing rapid development. Recently, leading Chinese automaker BYD Co., Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDD#OTC">BYDD</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44630091/teslas-ev-crown-at-risk-as-byd-closes-in-with-breakthrough-charging-tech">unveiled its fast-charging technology</a>, which could provide approximately 250 miles of range through a 5-minute charge.
In contrast, Tesla Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44245123/teslas-charging-empire-faces-headwinds-as-ev-market-stumbles">superchargers provide 170 miles</a> of range on a 10-minute charge, significantly lower than BYD's tech.
Check out more of Benzinga's Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link</a>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44892799/teslas-india-play-deepens-as-elon-musks-ev-giant-explores-alternate-semiconductor-supply-chains-amid-us-china-trade-war">Tesla&#8217;s India Play Deepens As Elon Musk&#8217;s EV Giant Explores Alternate Semiconductor Supply Chains Amid US-China Trade War</a></li>
</ul>
Image Via Shutterstock

Markets

BYDD

BYDDF

TSLA

VLKAF

Tesla Battery Supplier CATL Unveils New Fast-Charging Battery With 323-Mile Range In Five Minutes

The U.S. is accelerating the permitting process for 10 critical mineral production projects under the FAST-41 program following President Donald Trump's <a target="_blank" href="https://www.benzinga.com/government/regulations/25/03/44471105/trumps-executive-order-fuels-investor-speculation-over-alaskan-resources" rel="noreferrer noopener">executive order</a> to reduce the country's reliance on foreign mineral imports.
The initiative seeks to remove bureaucratic hurdles, secure essential minerals, and strengthen domestic supply chains.
"This is the first use of the Permitting Council's transparency authority, and we look forward to showcasing the many benefits the Federal Permitting Dashboard can bring to critical infrastructure projects," <a target="_blank" href="https://www.whitehouse.gov/articles/2025/04/trump-administration-advances-first-wave-of-critical-mineral-production-projects/" rel="noreferrer noopener">said</a> Manisha Patel, Acting Executive Director at the Permitting Council. "It's a vital tool for interagency coordination and efficient decision-making," he added.
The newly designated projects include major proposals across the country such as Perpetua Resources' (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>) Stibnite Gold and Antimony Project in Idaho, Rio Tinto's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) Resolution Copper Project in Arizona, Hecla Mining's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) copper and silver mine in Montana, and Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) expansion of the Silver Peak lithium mine in Nevada. Also included are Standard Lithium's direct lithium extraction site in Arkansas, Warrior Met Coal's metallurgical coal mine in Alabama, and the McDermitt Lithium Project in Oregon. Others include the Caldwell Canyon Phosphate Mine in Idaho, Lisbon Valley Copper in Utah, and Michigan Potash.
These projects are now subject to the FAST-41 framework, which provides enhanced interagency coordination and a centralized online dashboard for monitoring permitting progress. While the program doesn't waive environmental laws, it significantly improves process transparency and helps enforce clearer timelines.
The U.S. depends heavily on foreign sources, particularly China, for critical minerals such as lithium, copper, and rare earth elements, crucial for electric vehicles, military equipment, and consumer electronics. Lengthy permitting processes, which can take anywhere from <a target="_blank" href="https://www.benzinga.com/news/24/07/39870803/us-mine-development-delays-among-worlds-longest-second-only-to-zambia" rel="noreferrer noopener">10 to 29 years</a>, have hindered domestic production, forcing reliance on geopolitical competitors. By comparison, countries like Canada and Australia approve mines in two to five years, giving them a significant advantage in attracting investment and securing supply chains.
Even in Canada, where permitting is relatively faster, both leading candidates for prime minister—Mark Carney and Pierre Poilievre—have campaigned on promises to <a target="_blank" href="https://www.benzinga.com/25/04/44732611/canadian-politicians-promise-faster-project-approvals-ahead-of-april-28-elections" rel="noreferrer noopener">reduce mining bureaucracy</a> further.
"For too long, duplicative processes and regulatory paralysis have delayed the development of the minerals America needs," <a target="_blank" href="https://www.doi.gov/pressreleases/trump-administration-adds-key-mining-projects-fast-41" rel="noreferrer noopener">said</a> Adam Suess, Acting Assistant Secretary for Land and Minerals Management. "By cutting red tape and increasing accountability, we're making it clear that under President Trump, the United States is serious about being a global leader in critical minerals."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44891559/chinas-gold-stash-soars-to-2292-tonnesand-its-still-buying" target="_blank" rel="noreferrer noopener">China's Central Bank's Gold Stash Spikes To 2,292 Tonnes And Beijing Is Still Buying</a></li>
</ul>
Photo by Juan Roballo via Shutterstock

Large Cap

Commodities

Politics

Legal

PPTA

Trump Administration Fast-Tracks Ten Domestic Critical Mineral Projects

William Blair analyst Stephen Sheldon initiates coverage on Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) with a Market Perform rating.

William Blair Initiates Coverage On Zillow Gr with Market Perform Rating

Nano Dimension Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) ("Nano Dimension" or the "Company"), a leader in Digital Manufacturing solutions, today provided an update on Desktop Metal.
Desktop Metal, a subsidiary of Nano Dimension, has commenced a process to explore all available strategic alternatives to address its liabilities and liquidity needs. Desktop Metal has appointed Robert Warshauer to its Board of Directors and engaged Piper Sandler &amp; Co. and FTI Consulting, Inc. as financial advisers.
No assurances can be given as to the outcome or timing of the strategic review process. Nano Dimension plans to share additional details during its upcoming 2024 financial results and 2025 outlook call, expected to be held in late April 2025.

NNDM

Nano Dimension Announces Strategic Review for Desktop Metal to Address Liabilities and Liquidity Needs

Biotech

ZLAB

China's National Medical Products Administration Accepts Zai Lab's New Drug Application For Repotrectinib For Patients With NTRK-Positive Solid Tumors

QXO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) ("QXO" or the "Company") announced today that its wholly owned subsidiary, Queen MergerCo, Inc. ("Merger Sub"), intends to offer $2 billion in Senior Secured Notes due 2032 (the "Notes"), subject to market and other conditions. Merger Sub was formed in connection with QXO's previously announced acquisition of Beacon Roofing Supply, Inc. ("Beacon") under the Agreement and Plan of Merger dated March 20, 2025 (the "Merger Agreement").
Merger Sub intends to use the proceeds from the offering of the Notes, along with borrowings under new senior secured credit facilities, proceeds from QXO's previously announced equity offerings, and available balance sheet cash, to fund the transactions contemplated by the Merger Agreement and pay related fees and expenses.
Upon consummation of the acquisition, Merger Sub will merge with and into Beacon, with Beacon surviving as a wholly owned subsidiary of QXO. The Notes will be guaranteed on a senior secured basis by each of Beacon's wholly owned domestic restricted subsidiaries that guarantees Beacon's new senior secured term loan facility. The Notes and the related guarantees will be secured by first-priority liens on substantially all of Beacon's and the subsidiary guarantors' material owned assets other than ABL Priority Collateral (as defined below) and by second-priority liens on substantially all of Beacon's and the subsidiary guarantors' inventory and accounts receivable and related assets (the "ABL Priority Collateral"), in each case subject to certain exceptions and permitted liens.
The issuance and sale of the Notes and the related guarantees have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any other jurisdiction, and the Notes and the related guarantees are being offered and sold only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and to certain non-U.S. persons in offshore transactions outside the United States in reliance on Regulation S under the Securities Act.

QXO's Subsidiary Queen MergerCo Intends To Offer $2B In Senior Secured Notes Due 2032

In early 2009, when the financial crisis was still wreaking havoc, former Vice Chairman of Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) and former Chairman of Daily Journal Corporation, Charlie Munger, made an unusual choice that differentiated him from most investors.
While panic spread across global markets and stocks were being sold unthinkingly, Munger silently funnelled 71% of the Daily Journal Corporation's cash into suffering financial institutions, particularly Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>).
This turned out to be a masterstroke. By 2013, the value of those investments had increased three-fold, significantly boosting the company's worth.
Using Mental Models, Not Market Predictions: Munger didn't depend on forecasts or gut instinct, Chris Franco <a href="https://cmqinvesting.substack.com/p/how-charlie-munger-made-millions-after-2008-crash?r=4gn514&amp;utm_medium=ios&amp;triedRedirect=true">noted</a> in the CMQ Investing newsletter. Instead, he pursued a structured way of thinking that he called a &#8220;latticework of mental models.&#8221; 
Three main models grounded his investment choices: the Circle of Competence (only invest in businesses you understand in-depth), the Margin of Safety (buy at a price so low that even if things go sideways, there is still upside), and Opportunity Cost (allocate capital only when the potential return is better than any other option available).
These models created a strong, rational foundation for action when others were unsure of how to negotiate with uncertainty.
Understanding the Psychology of a Market Collapse: <a href="https://www.benzinga.com/markets/25/03/44450390/charlie-mungers-investment-wisdom-if-people-werent-so-often-wrong-we-wouldnt-be-so-rich">Munger's success </a>was rooted in his thorough understanding of human psychology. He consciously made sure not to fall into mental traps like Social Proof (following the crowd), Loss Aversion (being afraid of losses more than valuing gains), and Availability Bias (giving undue importance to recent traumatic events like the 2008 collapse).
He was not influenced by falling prices or sensational headlines. Instead, he gauged intrinsic value and based his thinking on facts, not fear.
See Also: <a href="https://www.benzinga.com/25/04/44855242/charlie-munger-once-highlighted-how-warren-buffetts-lifelong-learning-made-berkshire-hathaways-success-possible-and-the-crucial-lesson-you-can-take-from-it">Charlie Munger Once Said Warren Buffett Is A &#8216;Learning Machine&#8217; And That&#8217;s What Lies Beneath Berkshire Hathaway&#8217;s Success From One Decade To Another</a>
Why Munger's Strategy Still Matters Munger's strategy reminds us of age-old lessons: think for yourself, invest only when you understand the business, and leverage the fear-driven mispricing when it occurs. Munger's 2009 trade remains an extraordinary example of how <a href="https://www.benzinga.com/markets/equities/25/04/44681817/charlie-munger-once-said-the-market-wont-do-exactly-what-you-want-when-you-want-as-tariff-jitters-and-wild-swings-remind-investors-why-long-term-thinking-matters">long-term planning and emotional regulation </a>can generate incredible outcomes.
Berkshire's Cash Strategy Echoes Munger's Playbook Warren Buffett's record cash pile at Berkshire Hathaway is an example of Charlie Munger's 2009 approach in action—wait for fear to drive value. Armando Gonzalez, founder of AI-powered research platform Bigdata.com <a href="https://fortune.com/2025/03/15/warren-buffett-berkshire-hathaway-stock-market-correction-cash-pile-acquisitions/">told</a> Fortune that Buffett's moves demonstrate clear foresight: selling $134 billion in equities and <a href="https://www.benzinga.com/markets/equities/24/11/42153356/is-warren-buffett-preparing-for-a-market-downturn-with-berkshire-hathaways-325b-cash-pile-analyst-says-internet-bubble-and-2008-crash-may-have-lessons">building a $334.2 billion cash pile </a>in expectation of market turmoil.
Like Munger, Buffett is deploying patience as a strategic edge that will give him an advantage over others. Gonzalez observed that Buffett is not chasing rebounds or attempting to time the bottom—he's waiting for real bargains to appear, where the risk-reward balance tips conclusively in his favor.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44779752/charlie-munger-says-investors-who-cant-handle-market-volatility-deserve-the-mediocre-result">Charlie Munger Says Investors Who Can&#8217;t Handle Market Volatility &#8216;Deserve the Mediocre Result&#8217;</a></li>
</ul>
Photo Courtesy: Kent Sievers on Shutterstock.com

Success Stories

Charlie Munger's Bold Bank Bets In 2008: A Masterclass In Rational Investing And How Warren Buffett Is Now Channeling That Same Patience With A $334 Billion Cash Pile

Needham analyst John Todaro maintains Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) with a Buy and lowers the price target from $15 to $13.

BTDR

Needham Maintains Buy on Bitdeer Technologies, Lowers Price Target to $13

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management Team
Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to Execute Strategic Plan
Urges Stockholders to Defend Board Independence from Majority Influence by Individual 2.8% Stockholder, Mangless, Who Had Three Nominees Elected to the Board in 2023
Mangless Has Not Detailed any Strategies, Plans, or New Ideas to Improve Zevra's Business and Appears Solely Focused on Replacing Two Highly Qualified Directors
Board and Management Urge Stockholders to Vote "FOR" Zevra's Highly-Qualified and Experienced Director Nominees on the WHITE Proxy Card &nbsp;
CELEBRATION, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- &nbsp;Zevra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVRA#NASDAQ">ZVRA</a>) ("Zevra", or "the Company"), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it has filed its definitive proxy statement with the&nbsp;U.S. Securities and Exchange Commission&nbsp;(the "SEC") in connection with the Company's 2025 Annual Meeting of Stockholders ("Annual Meeting"), which is scheduled to take place on&nbsp;May 29, 2025. Stockholders of record as of&nbsp;April 4, 2025 will be entitled to vote at the Annual Meeting.
Zevra's Board of Directors strongly recommends that stockholders vote "FOR" the Company's two highly-qualified directors up for re-election on the WHITE proxy card – Wendy L. Dixon, Ph.D and Tamara A. Favorito, both of whom bring extensive public company board experience and life sciences management expertise to the Zevra Board. Both of these independent directors have contributed valuable perspectives that have helped accelerate the Company's progress and execution of its strategic goals.
In conjunction with the definitive proxy filing, Zevra is mailing a letter to stockholders detailing the decisive action the Company has taken over the past two years to transform Zevra into a stronger, growth-oriented commercial organization, which is poised to continue to drive significant stockholder value. The letter also addresses the attempt by an individual stockholder, Daniel J. Mangless, to replace two highly qualified directors with his nominees who could disrupt the clear progress underway and jeopardize Zevra's ability to deliver long-term value for stockholders.

ZVRA

Zevra Therapeutics Board And Management Urge Stockholders to Vote "FOR" Zevra's Director Nominees on WHITE Proxy Card

Loop Capital analyst Laura Champine upgrades Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) from Hold to Buy and announces $25 price target.

Comments

Edreams Odigeo

Interés en corto

Edreams Odigeo (OTC:EDDRF) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL